Filters
Topics
Campus & Community
Colleges & Schools

University of Texas bioengineer to lecture at Cornell April 18 and 19

George Georgiou, the Joe C. Walter Chair in Engineering at the University of Texas at Austin, will deliver the 18th annual Julian C. Smith Lectures in the School of Chemical and Biomolecular Engineering at Cornell University Monday, April 18, and Tuesday, April 19. Both talks will be given at 4 p.m. in 255 Olin Hall and will be preceded by a 3:15 p.m. reception in the Fred H. Rhodes Lounge in 128 Olin Hall. Both lectures are free and open to the public.

Beware of a dragon crossing (and vehicular delays) at Cornell March 18

Cornell University experts predict that the 104th beast created for the annual Dragon Day parade on campus will emerge from its lair Friday, March 18, and the university has issued the following traffic warning and road-closure alert: Vehicular access to central campus will be restricted from 12:30 p.m. to approximately 3:30 p.m. Buses could be rerouted or delayed when the dragon begins its journey across campus from Rand Hall at approximately 1 p.m. The beast will travel east on University Avenue, then south on East Avenue, then west on Campus Road. It will lumber through Ho Plaza and enter the Arts Quad, between Uris and Olin libraries, before proceeding to the south side of Sibley Hall.

Weill Cornell/ludwig institute for cancer research collaboration identifies two antigens as targets for multiple myeloma vaccine

Vaccines that train the immune system to seek out and destroy malignant cells are at the cutting edge of cancer treatment. Now, joint research – conducted by researchers at Weill Medical Cornell and at the Ludwig Institute for Cancer Research Memorial Sloan-Kettering Cancer Center Branch in New York – has pinpointed two proteins that seem ideal targets for a vaccine against multiple myeloma.

First-ever compounds to target only metastatic cells are highly effective against breast, prostate, and colon cancers

NEW YORK (March 16, 2005) -- Two compounds that zero in on cancer cells spreading throughout the body, while ignoring primary tumor cells, could someday give doctors a whole new weapon in the fight against tough-to-treat metastatic disease, according to Weill Medical College of Cornell University researchers.The compounds, called synthetic migrastatin analogues, prevented 91 to 99 percent of metastatic breast cancer cells in mice, and are the first to target only metastatic cells.

Weill Cornell research reveals secrets of trafficking within cells

NEW YORK (March 16, 2005) -- As you read this, cells in your eye are transmitting information to your brain, while cells in your heart and arteries work just as hard to keep that brain alive. Every one of these cells -- and others throughout the body -- depends on an internal process called endocytosis to keep the flow of cellular nutrients and information healthy and strong.It's an incredibly important life process, and now researchers at Weill Medical College of Cornell University in New York City have used an exciting new technology to better understand how one key player -- a protein called clathrin -- helps regulate endocytosis like a well-oiled machine. It may also give us insights into the kinds of disease states that can happen when clathrin-regulated endocytosis goes wrong.

Security flaw in popular peer-to-peer filesharing software found and patched by Cornell and Lime Wire LLC

A Cornell research group has discovered serious vulnerabilities in a widely-used peer-to-peer filesharing program. The weakness in LimeWire, a popular client for the Gnutella filesharing network.

Three promising and innovative prostate cancer therapies in clinical trials at New York-Presbyterian/Weill Cornell

Three promising and innovative prostate cancer therapies are currently being investigated in clinical trials at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The three trials include separate studies of two monoclonal antibody investigative therapies.

Heckscher Foundation awards $900,000 grant to Cornell Urban Scholars Program for its public service efforts in New York City

The Heckscher Foundation for Children recently awarded a $900,000 grant to the Cornell Urban Scholars Program, in which students from Cornell University help address challenges confronting New York City's poorest children, families and neighborhoods. The grant will provide three years of operational funds for the Urban Scholars Program.

Free science education DVD from Cornell, for a limited time only

Free  for a limited time only, is an educational DVD about the innovative national outreach Garden Mosaics Program.

In 'bittersweet' ceremony, Hans Bethe is posthumously awarded American Philosophical Society's Benjamin Franklin Medal

Three days after his death, Nobel laureate Hans Bethe, emeritus professor of physics at Cornell University and an architect of the age of modern atomic theory, was posthumously awarded the 2005 Benjamin Franklin Medal for Distinguished Achievement in the Sciences by the American Philosophical Society (APS).

After Sept. 11 attacks: As traveler plans changed from flying to driving, highway deaths rose in subsequent months

Beyond the tragic deaths on Sept. 11, 2001, there were more lives lost as an indirect result of the terrorist attacks. Using airline passenger and highway statistics, nearly 1,200 more people died in the months subsequent to the attacks when they switched their travel plans from flying to driving, according to Cornell University economists.

Cornell poll indicates that more than half of New Yorkers oppose Social Security reform to allow private investment

More than half of all New York state residents (51 percent) oppose President Bush's proposal to change Social Security by allowing individuals to privately invest a portion of their Social Security taxes, according to a poll by Cornell University's School of Industrial and Labor Relations Survey Research Institute (SRI). The poll found that only about one-third of residents (36 percent) surveyed support the proposal.